Bioprocess Capital Ventures (BCVF) is a Russia-based venture capital fund focused on early-stage investments in biotechnology, pharmaceuticals, and fine chemistry. The fund is managed by Bioprocess Capital Partners and targets science-driven companies developing innovative biomedical technologies. It operates within the Russian innovation ecosystem, supporting startups engaged in research-intensive sectors. BCVF invests at early stages, emphasizing commercialization of scientific advancements. Its strategy centers on advancing high-technology life sciences ventures within regional and international markets.